Cantor Fitzgerald, L. P.
- SEC CIK
- 0001024896
- Latest filing
- Aug 19, 2026
ADVM holding history
Adverum Biotechnologies, Inc. in every 13F filed by Cantor Fitzgerald, L. P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ADVM overviewAll 13F holders of ADVMFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −15,446−100.0% | Sold out | Holders |
| Q1 2025 | 15,446 | $67.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 15,446 | $72.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 15,446 | $108.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 15,446 | $106.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 15,446 | $218.4K | 0.1% | −370−2.3% | ReducedConverted for a 1-for-10 split | Holders |
| Q4 2023 | 158,160 | $119.1K | <0.1% | −1,900−1.2% | Reduced | Holders |
| Q3 2023 | 160,060 | $240.1K | <0.1% | −2,778−1.7% | Reduced | Holders |
| Q2 2023 | 162,838 | $258.9K | <0.1% | +20,000+14.0% | Added | Holders |
| Q1 2023 | 142,838 | $102.5K | <0.1% | +7,838+5.8% | Added | Holders |
| Q4 2022 | 135,000 | $78.0K | <0.1% | +115,000+575.0% | Added | Holders |
| Q3 2022 | 20,000 | $19.0K | <0.1% | +20,000 | New | Holders |